John D. Hummel

John D. Hummel

Auto-generated profile, based on publicly available information

John D. Hummel

The Ohio State University Wexner Medical Center, Columbus, Ohio

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
PDF file
AVAtul Verma
Atul Verma
LBLucas Boersma
Lucas Boersma
DHDavid E. Haines
David E. Haines
ANAndrea Natale
Andrea Natale
FMFrancis E. Marchlinski
Francis E. Marchlinski
BWBradley Wilsmore
Bradley Wilsmore
Background: Pulsed field ablation (PFA) is a novel form of ablation using electrical fields to ablate cardiac tissue. There are only limited data assessing the feasibility and safety of this type of ablation in humans. Methods: PULSED AF (Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF; https://www.clinicaltrials.gov ; unique identifier: NCT04198701) is a nonrandomized, prospective, multicenter, global, premarket clinical study. The first-in-human pilot phase evaluated the feasibility and efficacy of pulmonary vein isolation using a novel PFA system delivering bipolar, biphasic electrical fields through a circular multielectrode array catheter (PulseSelect; Medtronic, Inc). Thirty-eight patients with paroxysmal or persistent atrial fibrillation were treated in 6 centers in Australia, Canada, the United States, and the Netherlands. The primary outcomes were ability to achieve acute pulmonary vein isolation intraprocedurally and safety at 30 days. Results: Acute electrical isolation was achieved in 100% of pulmonary veins (n=152) in the 38 patients. Skin-to-skin procedure time was 160±91 minutes, left atrial dwell time was 82±35 minutes, and fluoroscopy time was 28±9 minutes. No serious adverse events related to the PFA system occurred in the 30-day follow-up including phrenic nerve injury, esophageal injury, stroke, or death. Conclusions: In this first-in-human clinical study, 100% pulmonary vein isolation was achieved using only PFA with no PFA system–related serious adverse events. Graphic A graphic abstract is available for this article.

26 July 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
NLNing Li
Ning Li
BHBrian J. Hansen
Brian J. Hansen
TCThomas A. Csepe
Thomas A. Csepe
JZJichao Zhao
Jichao Zhao
AIAnthony J. Ignozzi
Anthony J. Ignozzi
VFVadim V. Fedorov
Vadim V. Fedorov
Multiple redundant and diverse intranodal pacemakers and conduction pathways allow the human sinoatrial node to robustly maintain cardiac rhythm.

1 February 2014 in Heart Rhythm
Verified
Journal Article
Closed access
JHJohn Hummel
John Hummel
GMGregory Michaud
Gregory Michaud
RHRobert Hoyt
Robert Hoyt
DDDavid DeLurgio
David DeLurgio
ARAbdi Rasekh
Abdi Rasekh
LBLucas Boersma
Lucas Boersma

17 November 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
PDF file
RSReynaldo Sanchez
Reynaldo Sanchez
ANAnish Nadkarni
Anish Nadkarni
BBBenjamin Buck
Benjamin Buck
GDGeorges Daoud
Georges Daoud
TKTanner Koppert
Tanner Koppert
MAMuhammad R. Afzal
Muhammad R. Afzal
Introduction: Frequent right AQ4ventricular pacing (≥40%) with a transvenous pacemaker (TVP) is associated with the risk of pacing‐induced cardiomyopathy (PICM). Leadless pacemakers (LPs) have distinct physical and mechanical differences from TVP. The risk of PICM with LP is not known. To identify incidence, predictors, and long‐term outcomes of PICM in LP and TVP patients.Methods: The study comprised all pacemaker‐dependent patients with LP or TVP who had left ventricular ejection fraction (LVEF) of ≥50 from 2014 to 2019. The incidence of PICM (≥10% LVEF drop) was assessed with an echocardiogram. Predictors for PICM were identified using multivariate analysis. Long‐term outcomes after cardiac resynchronization (CRT) were assessed in both groups.Results: A total of 131 patients with TVP and 67 with LP comprised the study. All patients in the TVP group and the majority in the LP group underwent atrioventricular node ablation. The mean follow‐up duration in TVP and LP groups was 592 ± 549 and 817 ± 600 days, respectively. A total of 18 (13.7%) patients in TVP and 2 (3%) in LP developed PICM after a median duration of 254 (interquartile range: 470) days. The incidence of PICM was significantly higher with TVP compared with LP (p = .02). TVP as pacing modality was a positive (odds ratio [OR]: 1.07) while age was negative (OR: 0.94) predictor for PICM on multivariable analysis. Both patients in LP and all except two in the TVP group responded to CRT.Conclusion: Incidence of PICM is significantly lower with LP compared with TVP in pacemaker‐dependent patients. Age and TVP as pacing modality were predictors for PICM.

1 December 2022 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
JPJonathan P. Piccini
Jonathan P. Piccini
AUAndrea M Cooper Medical School of Rowan University
Andrea M Cooper Medical School of Rowan University
PSParikshit Sharma
Parikshit Sharma
JKJordana Kron
Jordana Kron
WTWendy Tzou
Wendy Tzou
PWPaul J. Wang
Paul J. Wang
Despite the global COVID-19 pandemic, during the past 2 years, there have been numerous advances in our understanding of arrhythmia mechanisms and diagnosis and in new therapies. We increased our understanding of risk factors and mechanisms of atrial arrhythmias, the prediction of atrial arrhythmias, response to treatment, and outcomes using machine learning and artificial intelligence. There have been new technologies and techniques for atrial fibrillation ablation, including pulsed field ablation. There have been new randomized trials in atrial fibrillation ablation, giving insight about rhythm control, and long-term outcomes. There have been advances in our understanding of treatment of inherited disorders such as catecholaminergic polymorphic ventricular tachycardia. We have gained new insights into the recurrence of ventricular arrhythmias in the setting of various conditions such as myocarditis and inherited cardiomyopathic disorders. Novel computational approaches may help predict occurrence of ventricular arrhythmias and localize arrhythmias to guide ablation. There are further advances in our understanding of noninvasive radiotherapy. We have increased our understanding of the role of His bundle pacing and left bundle branch area pacing to maintain synchronous ventricular activation. There have also been significant advances in the defibrillators, cardiac resynchronization therapy, remote monitoring, and infection prevention. There have been advances in our understanding of the pathways and mechanisms involved in atrial and ventricular arrhythmogenesis.

1 September 2020 in Heart Rhythm
Verified
Journal Article
Closed access
MAMuhammad R. Afzal
Muhammad R. Afzal
CEChristopher R. Ellis
Christopher R. Ellis
JGJames Gabriels
James Gabriels
MEMikhael El-Chami
Mikhael El-Chami
AAAnish Amin
Anish Amin
JHJohn D. Hummel
John D. Hummel